Every Cochrane Review reflects both a substantial commitment of time and expertise on the part of the review author team and all the editors, information specialists and peer reviewers based at the relevant Cochrane Review Group. The work undertaken and the rigour of the process are both focused on ensuring that the best quality evidence from research may inform decision makers.
Cochrane Review shows how a cheaper alternative to licensed drug for treating eye disease has similar side effects
Neovascular macular degeneration is a progressive and chronic disease of the eye, and a leading cause of blindness in older people globally.
About one in 10 people with macular degeneration suffers legal blindness.
In a recent story, US-based Fox News discusses the publication of a number of major studies, including a Cochrane Review, assessing aspects of smoking addiction and behaviour, and how the results might be integrated for effective public health intervention.